The predictors of prostate cancer in the Melbourne Collaborative Cohort Study
墨尔本合作队列研究中前列腺癌的预测因素
基本信息
- 批准号:nhmrc : 126402
- 负责人:
- 金额:$ 23.9万
- 依托单位:
- 依托单位国家:澳大利亚
- 项目类别:NHMRC Project Grants
- 财政年份:2000
- 资助国家:澳大利亚
- 起止时间:2000-01-01 至 2002-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In 1990 we set up a long-term study of diet and health. The aim was to measure diet and other risk factors in healthy people in order to see how they might affect future development of cancer. To do this we recruited 41,500 people aged 40 to 69, measured what they ate and drank, and collected information on other aspects of lifestyle, medical history, and family history of common diseases. All had height and weight and blood pressure measured and gave a blood sample. People were selected so that men and women and migrants from Italy and Greece would be included. In this way we could widen the range of dietary habits, other lifestyle factors and genetic variation (measured in DNA from blood). Since then participants have completed another questionnaire and instances of disease have been noted from self reports and from examining medical records. We want to analyse data from 700 men in the study who have developed prostate cancer (PC). First we will analyse data collected on all 17,000 men (collected when joining the study, and at follow up). Next we will use data from only the 700 men with PC and 1400 men who have not developed PC. This study will focus on measuring substances in the blood. We want to measure a range of fats, vitamins, antioxidants and phytoestrogens, as well as male sex hormones and related substances. In the DNA from the blood we plan to measure variations in genes that influence how male sex hormones and other growth factors important in the prostate are produced and used. We will then be able to estimate what affect these factors have on the risk of getting PC. We will also be able to see if any of them act together to make the risk of PC much higher in certain men. This work should identify what lifestyle factors could reduce the risk of PC. It should also identify what genetic variations are associated with increased risk of PC and thus identify a sub group of men who might benefit from early medical attention or from changes in lifestyle.
1990年,我们设立了饮食与健康的长期研究。目的是测量健康人的饮食和其他危险因素,以了解它们如何影响癌症的未来发展。为此,我们招募了 41,500 名年龄在 40 至 69 岁之间的人,测量了他们的饮食情况,并收集了生活方式、病史和常见疾病家族史等其他方面的信息。所有人都测量了身高、体重和血压,并提供了血样。经过挑选的人员包括来自意大利和希腊的男性、女性以及移民。通过这种方式,我们可以扩大饮食习惯、其他生活方式因素和遗传变异(通过血液 DNA 测量)的范围。从那时起,参与者完成了另一份调查问卷,并从自我报告和检查医疗记录中记录了疾病实例。我们想要分析研究中 700 名患有前列腺癌 (PC) 的男性的数据。首先,我们将分析所有 17,000 名男性收集的数据(在加入研究时和随访时收集)。接下来,我们将仅使用 700 名拥有 PC 的男性和 1400 名尚未发展 PC 的男性的数据。这项研究将重点测量血液中的物质。我们想要测量一系列脂肪、维生素、抗氧化剂和植物雌激素,以及男性性激素和相关物质。我们计划在血液 DNA 中测量影响男性性激素和前列腺中重要的其他生长因子如何产生和使用的基因变异。然后我们将能够估计这些因素对患 PC 风险的影响。我们还将了解它们中的任何一个共同作用是否会导致某些男性患 PC 的风险更高。这项工作应确定哪些生活方式因素可以降低 PC 风险。它还应该确定哪些遗传变异与 PC 风险增加相关,从而确定可能受益于早期医疗护理或生活方式改变的男性亚组。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Prof Graham Giles其他文献
Prof Graham Giles的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Prof Graham Giles', 18)}}的其他基金
LIFEPATH: life-course biological pathways underlying social differences in healthy ageing
LIFEPATH:健康老龄化社会差异背后的生命历程生物学途径
- 批准号:
nhmrc : 1106016 - 财政年份:2015
- 资助金额:
$ 23.9万 - 项目类别:
Targeted Calls
Linking lifestyle and molecular biology to inform "Precision Public Health" for major cancers
将生活方式和分子生物学联系起来,为主要癌症提供“精准公共卫生”
- 批准号:
nhmrc : 1074383 - 财政年份:2015
- 资助金额:
$ 23.9万 - 项目类别:
Program Grants
LIFEPATH: life-course biological pathways underlying social differences in healthy ageing
LIFEPATH:健康老龄化社会差异背后的生命历程生物学途径
- 批准号:
nhmrc : GNT1106016 - 财政年份:2015
- 资助金额:
$ 23.9万 - 项目类别:
International Collaborations
Linking lifestyle and molecular biology to inform "Precision Public Health" for major cancers
将生活方式和分子生物学联系起来,为主要癌症提供“精准公共卫生”
- 批准号:
nhmrc : GNT1074383 - 财政年份:2015
- 资助金额:
$ 23.9万 - 项目类别:
Programs
相似国自然基金
ELL在前列腺癌发生中的负性作用机制及其临床意义
- 批准号:81101948
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
miRNA let-7a下调IGF1R抑制前列腺癌细胞雄激素非依赖性生长的作用机制
- 批准号:81071720
- 批准年份:2010
- 资助金额:31.0 万元
- 项目类别:面上项目
前列腺癌冷冻消融后HMGB1调节冷冻免疫反应相关机制研究
- 批准号:81001002
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
晚期糖基化终产物受体与视网膜母细胞瘤蛋白在前列腺癌细胞中的相互作用及意义
- 批准号:30700835
- 批准年份:2007
- 资助金额:16.0 万元
- 项目类别:青年科学基金项目
Kallikrein 4(KLK4)受激素调控的机制和对激素非依赖前列腺癌生长影响的实验研究
- 批准号:30571853
- 批准年份:2005
- 资助金额:27.0 万元
- 项目类别:面上项目
相似海外基金
Evaluation of novel microscale cell culture platform for translational drug development in prostate cancer
用于前列腺癌转化药物开发的新型微型细胞培养平台的评估
- 批准号:
10588604 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Novel modalities for prostate cancer screening: mast cells as predictors of disease, disease aggressiveness and marks of disease disparity
前列腺癌筛查的新方法:肥大细胞作为疾病、疾病侵袭性和疾病差异标志的预测因子
- 批准号:
10650620 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Validating the performance and inclusivity of a novel functionally-informed predictive genetic test method for polygenic disease
验证多基因疾病的新型功能信息预测基因测试方法的性能和包容性
- 批准号:
10759476 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Comprehensive characterization of prostate stromal gene expression and association with lethal prostate cancer
前列腺基质基因表达的综合表征及其与致死性前列腺癌的关联
- 批准号:
10759608 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Early Detection of Pancreatic Cancer with Human-in-the-Loop Deep Learning
通过人在环深度学习早期检测胰腺癌
- 批准号:
10592060 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
GPR160 antibody development for cancer treatment
用于癌症治疗的 GPR160 抗体开发
- 批准号:
10711206 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Tailored prostate cancer screening: addressing USPSTF priority research gaps in a racially-diverse study population
量身定制的前列腺癌筛查:解决 USPSTF 在种族多样化研究人群中的优先研究差距
- 批准号:
10735739 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Uncovering causal protein markers to improve prostate cancer etiology understanding and risk prediction in Africans and Europeans
发现因果蛋白标记物以提高非洲人和欧洲人对前列腺癌病因的了解和风险预测
- 批准号:
10647719 - 财政年份:2022
- 资助金额:
$ 23.9万 - 项目类别:
Enhancing the Efficacy of Docetaxel in Prostate Cancer
增强多西紫杉醇治疗前列腺癌的疗效
- 批准号:
10665071 - 财政年份:2022
- 资助金额:
$ 23.9万 - 项目类别:
The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screening
肺早蛋白项目:在肺癌筛查中实施生物标志物的飞跃
- 批准号:
10700985 - 财政年份:2022
- 资助金额:
$ 23.9万 - 项目类别: